Author:
Kuroda Takeshi,Sato Hiroe,Nakatsue Takeshi,Wada Yoko,Murakami Shuichi,Nakano Masaaki,Narita Ichiei
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference43 articles.
1. Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, Wolfe F: Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford). 2002, 41: 1346-1356. 10.1093/rheumatology/41.12.1346.
2. Krause D, Scleusser B, Herborn G, Rau R: Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum. 2000, 43: 14-21. 10.1002/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7.
3. Searles G, McKendry RJR: Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four cases reports and a review of the literature. J Rheumatol. 1987, 14: 1164-1171.
4. Carson CW, Cannon GW, Egger MJ, Ward JR, Clegg DO: Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum. 1987, 16: 186-195. 10.1016/0049-0172(87)90021-7.
5. Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Lesile AL, Cook NJ, D’Souza I: Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol. 1994, 21: 51-54.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献